Correlation Between Viridian Therapeutics and Pentair PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Pentair PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Pentair PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Pentair PLC, you can compare the effects of market volatilities on Viridian Therapeutics and Pentair PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Pentair PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Pentair PLC.

Diversification Opportunities for Viridian Therapeutics and Pentair PLC

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Viridian and Pentair is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Pentair PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pentair PLC and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Pentair PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pentair PLC has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Pentair PLC go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Pentair PLC

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.23 times less return on investment than Pentair PLC. In addition to that, Viridian Therapeutics is 2.55 times more volatile than Pentair PLC. It trades about 0.04 of its total potential returns per unit of risk. Pentair PLC is currently generating about 0.13 per unit of volatility. If you would invest  6,355  in Pentair PLC on August 24, 2024 and sell it today you would earn a total of  4,271  from holding Pentair PLC or generate 67.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy96.46%
ValuesDaily Returns

Viridian Therapeutics  vs.  Pentair PLC

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Pentair PLC 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pentair PLC are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Pentair PLC unveiled solid returns over the last few months and may actually be approaching a breakup point.

Viridian Therapeutics and Pentair PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Pentair PLC

The main advantage of trading using opposite Viridian Therapeutics and Pentair PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Pentair PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pentair PLC will offset losses from the drop in Pentair PLC's long position.
The idea behind Viridian Therapeutics and Pentair PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated